Pilot study of prospective administration of nanocrystallized fenofibrate in humans with COVID-19 treated with standard-of-care
respiratory deterioration, pneumonia
PNEUMONIA
To further assess the clinical relevance of our findings, we performed an interventional single-arm clinical study in severe, hospitalized COVID-19 patients, who exhibited respiratory deterioration and severe pneumonia (NCT04661930; 